文献速递眼底病与葡萄膜炎

息肉状脉络膜血管病变:定义、发病机制、诊断与管理

Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.
PubMed 文献 · Ophthalmology · 2018-01-10

息肉状脉络膜血管病变(PCV)是年龄相关性黄斑变性(AMD)亚型,尤其见于亚洲人群。综述总结了其流行病学、发病机制、影像学进展及治疗试验,重点介绍两项大型多中心随机临床试验提供的I级证据,并提出当前管理指南与建议。

要点

  • PCV是AMD亚型,尤其见于亚洲人群,抗VEGF单药与联合PDT的治疗选择此前不明确。
  • OCT研究提示PCV属于以厚脉络膜为特征的一组疾病,脉络膜循环障碍似乎是其发病机制的核心。
  • 增强深度成像、扫频源OCT、en face OCT和OCT血管成像等影像学进展促进了PCV诊断。

核心结论

  • 综述总结了PCV的流行病学、发病机制、影像学及治疗试验的最新进展,并提出了当前管理指南与建议。
  • 两项评估抗VEGF单药与联合光动力疗法(PDT)的大型多中心随机临床试验报告了首年结果,提供了指导临床选择最合适治疗的I级证据。
  • PCV认识中仍存在空白,如息肉闭合的意义、高复发率和PCV内的异质性,尚需进一步研究。

研究设计与样本

  • 综述类文章,总结PCV的流行病学特征、发病机制、影像学进展和治疗试验,重点关注最新关键临床试验。

主要发现

  • 既往研究提示PCV与典型AMD对玻璃体腔注射抗血管内皮生长因子(VEGF)药物的反应存在差异。
  • 基于OCT的影像学研究提示PCV属于以厚脉络膜为特征的一组疾病,脉络膜循环障碍似乎是其发病机制的核心。
  • 增强深度成像、扫频源OCT、en face OCT和OCT血管成像等影像学进展促进了PCV的诊断。
  • 两项大型多中心随机临床试验评估了抗VEGF单药及联合PDT的安全性和有效性,并报告了首年结果。

临床怎么用

  • 综述提出了当前管理指南与建议,以帮助临床医生管理PCV患者。

局限性

  • 当前对PCV的认识仍存在空白,如息肉闭合的意义、高复发率和PCV内的异质性,尚需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Polypoidal choroidal vasculopathy (PCV) is an age-related macular degeneration (AMD) subtype and is seen particularly in Asians. Previous studies have suggested disparity in response to intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents between PCV and typical AMD, and thus, the preferred treatment for PCV has remained unclear. Recent research has provided novel insights into the pathogenesis of PCV, and imaging studies based on OCT suggest that PCV belongs to a spectrum of conditions characterized by pachychoroid, in which disturbance in the choroidal circulation seems to be central to its pathogenesis. Advances in imaging, including enhanced depth imaging, swept-source OCT, en face OCT, and OCT angiography, have facilitated the diagnosis of PCV. Importantly, 2 large, multicenter randomized clinical trials evaluating the safety and efficacy of anti-VEGF monotherapy and combination with photodynamic therapy (PDT) recently reported initial first-year outcomes, providing level I evidence to guide clinicians in choosing the most appropriate therapy for PCV. In this review, we summarize the latest updates in the epidemiologic features, pathogenesis, and advances in imaging and treatment trials, with a focus on the most recent key clinical trials. Finally, we propose current management guidelines and recommendations to help clinicians manage patients with PCV. Remaining gaps in current understanding of PCV, such as significance of polyp closure, high recurrence rate, and heterogeneity within PCV, are highlighted where further research is needed.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Cheung CMG, Lai TYY, Ruamviboonsuk P, et al. Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management. Ophthalmology. 2018. PMID: 29331556. doi:10.1016/j.ophtha.2017.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。